Repository logo
Log In(current)
  1. Home
  2. Colleges & Schools
  3. Graduate School
  4. Masters Theses
  5. Copper Catalyzed Precision Deuteration of Unactivated 1,1-Disubstituted Alkenes and Development of 64Cu-DOTA-Erdafitinib Complex for Bladder Cancer Diagnosis and Treatment
Details

Copper Catalyzed Precision Deuteration of Unactivated 1,1-Disubstituted Alkenes and Development of 64Cu-DOTA-Erdafitinib Complex for Bladder Cancer Diagnosis and Treatment

Date Issued
August 2026
Author(s)
García Padín, Gabriel Enrique
The University of Tennessee
Advisor(s)
Joseph Clark
Additional Advisor(s)
Shawn Campagna
Brendon McNicholas
Permanent URI
https://trace.tennessee.edu/handle/20.500.14382/61655
Abstract
Isotopically active compounds are crucial compounds for the use of internal standards, pharmacokinetic studies and development of novel drugs. Molecules with deuterium, an isotope of hydrogen, can enhance drug properties within the body when located at specific sites within the molecule. Copper-catalyzed precision deuteration of small molecules and its prominent reactivity with unactivated 1,1-disubstituted alkenes is described. Interchangeable deuterium sources allowed the selective installation of a single deuterium at primary or tertiary position on the newly reduced aliphatic chain. Deuterium incorporation %90< showed high selectivity for a specific region with no deuterium scrambling, demonstrating late-stage applicability and chemo-selectivity across various substrates. While integration of various isotopes of Hydrogen within a molecule is extremely useful, the development of drugs that transport external radiolabeled isotopes is also crucial for theragnostic purposes. Development of [64Cu] complexes is useful due to the radio emission profile upon cells, half-life convenience and ease of production for PET imaging. However, Radiometals like [64Cu] are not selective in vivo. When chelated to certain molecules, these can be linked to target specific drugs, forming a [64Cu]-chelator-drug complex capable to accurately diagnose and treat illness. This presents opportunity for the development of novel and potentially selective in vivo [64Cu]-DOTA-Erdafitinib complexes for the diagnosis and treatment of bladder cancer. Current experiments described here show successful synthesis of a [64Cu]-DOTA-Erdafitinib precursor.
Subjects

Precision Deuteration...

Transfer Hydrodeutera...

Deuterium

Copper catalyzed tran...

Olefin reduction

Tertiary and Primary ...

Degree
Master of Science
Major
Organic Chemistry
Embargo Date
August 1, 2029

University Libraries

1015 Volunteer Boulevard
Knoxville, TN 37996
865-974-4351

Map & Directions
Donate to the Libraries
  • About
  • John C. Hodges Society
  • Speaking Volumes magazine
  • Outreach
  • Directory
  • Employment
  • Policies
  • Library Intranet
University of Tennessee power T logo

The University of Tennessee, Knoxville
Knoxville, Tennessee 37996
865-974-1000

Events
A-Z
Apply
Privacy
Map
Directory
Give to UT
Accessibility

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science